Lung Ultrasound for Predicting Outcome of Weaning From Mechanical Ventilation
NCT ID: NCT03880864
Last Updated: 2019-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
50 participants
INTERVENTIONAL
2019-03-07
2020-01-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Ultrasound Score and Weaning Outcome
NCT05289960
Role of Lung Ultrasound in Weaning From Mechanical Ventilation in Postoperative Neurosurgical ICU Patients
NCT03921112
Lung and Diaphragm Ultrasound in Predicting Extubation and Weaning of Mechanically Ventilated Patients in Intensive Care Unit
NCT07057804
Lung Ultrasound Assisting Weaning in Difficult-to-wean Patients
NCT01724034
Diaphragmatic Thickening Fraction as a Predictor of Successful Weaning
NCT06465082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical assessment during and after SBT:
* The ability of maintaining a respiration rate of less than 35/min, and keeping oxygen saturation more than 90%.
* Arterial blood gases (ABGs) will be done 30-60 minutes after SBT and after extubation.
* To detect signs of respiratory distress: diaphoresis, tachypnea (RR\> 35/min), increase activity of accessory muscles of respiration, tachycardia (heart rate \> 140 beats per minute), systolic blood pressure \> 180 mmHg or \<90 mmHg, appearance of new arrhythmia, or alteration in mental status (drowsiness or anxiety). ABGs: PaO2 ≤ 60 mmHg or oxygen saturation \< 90% on FiO2 ≥ 0.4, PaCO2 \> 50 mmHg, or an increase in by ≥ 8 mmHg, pH \< 7.32 or a decrease in pH by ≥ 0.07 pH units.
Clinical assessment will be done by an intensivist who will be blinded to the LUS score results.
Lung ultrasound (LUS): will be performed while patients in supine position, with a curved probe on B- mode, using longitudinal view, to assess the amount of lung aeration. Each lung will be divided into anterior, lateral and posterior regions, each part will be divided to upper and lower zone, with total of 12 zones to undergo examination. Examination will be done by an expert physician in US.
Lung US score \[9\]: The 12 scanned regions will be summed to calculate the LUS score, which ranged from 0 and 36. In each zone, the worst ultrasound form will considered to be descriptive of the entire region.
* Score of 0: Normal aeration is signified by the presence of horizontal A lines, lung sliding, or less than 3 vertical B lines.
* Score of 1: moderate loss of aeration is characterized by multiple regularly or irregularly spaced B lines that originated from the pleural line.
* Score of 2: Severe loss of aeration is manifested by multiple coalescent B lines in several intercostal spaces of the specific zone. Detected in alveolar-interstitial syndrome.\[
* Score of 3: Complete loss of aeration, as detected in lung consolidation or atelectasis, is characterized by tissue echogenicity, which is similar to liver or splenic tissues.
The score will be performed before starting and at the end of SBT (before extubation), or on developing respiratory distress during SBT.
Patients will be classified according to the possible outcome:
Successful weaning: patients who will not need re-intubation within 48 hours after extubation.
SBT failure: which will be diagnosed by the appearance of signs of respiratory distress during SBT and patients will be connected again to the ventilator. Extubation failure: will be defined as patients who developed signs of respiratory distress after extubation within 48hs and need reintubation or non-invasive ventilatory support.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound
Lung ultrasound
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mechanically ventilated via an endotracheal tube for more than 24 hours.
* Patients that have an improvement in the underlying cause of respiratory failure.
Exclusion Criteria
* Spinal cord injury above than T8
* Arrhythmias and or haemodynamic instability
* Patients having pneumothorax, or pneumomediastinum, chest tube or chest injuries.
* After thoracostomy, and pleural lesions or pleurodesis.
* Patients having severe chronic obstructive pulmonary disease (COPD) with forced expiratory volume less than 50% of predictive value.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randa Ali Shoukry
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Randa Ali Shoukry
Cairo, Al-Nozha, Egypt
Randa Ali Shoukry
Cairo, Al-Nozha, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU R 12/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.